期刊文献+

尼尔雌醇对绝经后妇女高脂血症的疗效观察 被引量:1

The Efficiency of Nylestriol in Treatment of Hyperlipidemia of Women in Postmenopause
暂未订购
导出
摘要 目的观察尼尔雌醇对绝经后妇女高脂血症的疗效。方法将 5 0例绝经后高脂血症妇女随机分为治疗组和对照组 ,治疗组 30例口服尼尔雌醇治疗 ;对照组 2 0例口服维生素E治疗。结果两组用药前TC、TG、HDL -C、VLDI-C无显著性差异 ;治疗组在用药后TC、TG无显著性变化 (P >0 .0 5 ) ;LDL -C、VLDL -C在治疗后 3个月及 6个月显著下降 (P <0 .0 1 ) ,HDL -C较治疗前明显升高 (P <0 .0 1 ) ;对照组各项血脂指标无显著性变化 (P >0 .0 5 )。 Objective To observe the effect of Nylestriol in treatment of hyperlipidemia of women in postmenopause.Methods 50 women in postmenopause were divided into treatment group and control group.In the former,30 patients were treated with Nyl,PO,while in control group,20 patients with Vit.E.Results There were no significant differences in TC,TG,HDL-C,LDL-C,VLDL-C between the two groups before treatment.In treatment group there were no significant changes in TC,TG affer treatment(P&gt;0.05),but the LDL-C,VLDL-C were decreased remarkably after 3 mouths and 6 months,and HDL-C were increased remarkably after treatment(P&lt;0.01).All types of blood lipids indexes had no significant changes in control group(P&gt;0.05).Conclusion Nylestriol is effective for treatment of hyperlipidemia of women in postmenopause.
出处 《咸宁医学院学报》 2002年第3期187-188,共2页 Journal of Xianning Medical College
关键词 尼尔雌醇 绝经后 妇女 高脂血症 疗效观察 Nylestriol Hyperlipidemia Postmenopause
  • 相关文献

参考文献1

二级参考文献3

  • 1程国钧,中华妇产科杂志,1991年,26卷,349页
  • 2Qian X X,Chinese Medical Journal,1990年,103卷,380页
  • 3程国钧,中华妇产科杂志,1990年,25卷,202页

共引文献15

同被引文献28

  • 1MacLennan A, Lester S, Moore, V. Oral oestrogen replacement therapy versus placebo for hot flushes [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 20-November2002. Date of Most Recent Substantive Update: 19-September-2000
  • 2Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endomertial hyperplasia and irregular bleeding ( Cochrane Review) [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 18-November-2002. Date of Most Recent Substantive Update: 24-February-1999
  • 3Norman RJ, Flight IHK, Rees MCP. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution ( Cochrane Review )[DB/OL]. Cochrane Library, Date of Most Recent Update: 20-November-2002. Date of Most Recent Substantive Update: 13-May-1999
  • 4Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV,Johnson .KC, Kotchen JM, Ockene J. Writing group for the Women's Health Initiative investigation. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial[J]. JAMA, 2002; 288 (3): 321 - 333
  • 5Al-Azzawi F, Wahab M, Habiba M, Akkad A, Mason T.Continuous combined hormone replacement therapy compared with tibolone [ J ]. Obstetrics & Gynecology, 1999; 93 (2):258 -264
  • 6Kokcu A, Cetinkaya MB, Yanik F, Alper T, Malatyalioglu E.Thecomparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women [ J]. Maturitas, 2000; 36 ( 1 ): 75-80
  • 7Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability[J]. Climacteric,2002; 5 ( 1 ): 60 - 69
  • 8Gregoriou O, Vitoratos N, Papadias C, Konidaris S, CostomenosD, Chryssikopoulos A. Effect of tibolone on postmenopausal women with myomas[J]. Maturitas, 1997; 27 (2): 187-191
  • 9Fedele L, Bianchi S, Raffaelli R. Zanconato G. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas [ J ]. European Journal of Obstetrics, Gynecology, & Reproductive Biology,2000; 88(1): 91-94
  • 10Simsek T, Karakus C, Trak B. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system [ J ]. Maturitas,2002; 42 ( 3 ): 243 - 246

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部